Table 2.
Variable | Treatment Group |
|||
---|---|---|---|---|
DASH+WM (n=43) | DASH-A (n=38) | Control (n=38) | Full Cohort (n=124) | |
Men, n (%) | 15 (35) | 15 (39) | 15 (35) | 45 (36) |
Whites, n (%) | 29 (74) | 17 (47) | 22 (54) | 68 (59) |
Age, y | 52.9 (10.4) | 52.3 (9.5) | 51.7 (9.0) | 52.3 (9.6) |
College degree, n (%) | 27 (63) | 23 (61) | 18 (42) | 68 (55) |
IMT, mm | 0.68 (0.17) | 0.70 (0.11) | 0.71 (0.13) | 0.70 (0.14) |
FSRP | 6.0 (2.6) | 6.2 (3.2) | 5.8 (2.5) | 6.0 (2.8) |
Clinic SBP, mm Hg | 138.6 (8.1) | 137.5 (8.5) | 138.6 (8.7) | 138.3 (8.4) |
Clinic DBP, mm Hg | 85.4 (7.2) | 87.2 (6.4) | 85.7 (5.9) | 86.1 (6.5) |
Peak oxygen consumption, mL/kg per min | 23.7 (6.5) | 23.5 (6.7) | 23.6 (6.0) | 23.6 (6.3) |
Weight, kg | 93.9 (14.5) | 93.9 (13.2) | 92.8 (15.2) | 93.5 (14.3) |
BMI, kg/m2 | 32.8 (4.1) | 32.8 (3.4) | 32.7 (3.9) | 32.8 (3.8) |
Data are given as mean (SD) unless otherwise indicated. FSRP indicates Framingham Stroke Risk Profile.